Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H. A. Verhoeven

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
Sex differences in treatment allocation and survival of potentially curable gastroesophageal cancer: A population-based studyMarianne C Kalff, Willemieke P M Dijksterhuis, Anna D Wagner, et al.
ESMO Open|December 11, 2024
Sex differences in the pharmacokinetics of anticancer drugs: a systematic reviewJ Delahousse, A D Wagner, S Borchmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2024
Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide studyKaren Van Der Sluis, Steven N Taylor, Liudmila L Kodach, et al.
International Journal of Cancer|July 25, 2019
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marije Slingerland, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2021
Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based studyAli Al-Kaabi, Rachel S van der Post, Leonie R van der Werf, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2018
Clinical lymph node staging in colorectal cancer; a flip of the coin?Nelleke P M Brouwer, Rutger C H Stijns, Valery E P P Lemmens, et al.
The Lancet Regional Health. Europe|April 6, 2026
Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based studyDillen C van der Aa, Mats D Teeken, Hanneke W M van Laarhoven, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2024
Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the NetherlandsJulie F M Geerts, Marieke Pape, Pauline A J Vissers, et al.
Annals of Surgical Oncology|February 6, 2019
Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal CancerZ Faiz, M van Putten, R H A Verhoeven, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
Sex differences in treatment allocation and survival of potentially curable gastroesophageal cancer: A population-based studyMarianne C Kalff, Willemieke P M Dijksterhuis, Anna D Wagner, et al.
ESMO Open|December 11, 2024
Sex differences in the pharmacokinetics of anticancer drugs: a systematic reviewJ Delahousse, A D Wagner, S Borchmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2024
Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide studyKaren Van Der Sluis, Steven N Taylor, Liudmila L Kodach, et al.
International Journal of Cancer|July 25, 2019
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marije Slingerland, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2021
Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based studyAli Al-Kaabi, Rachel S van der Post, Leonie R van der Werf, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2018
Clinical lymph node staging in colorectal cancer; a flip of the coin?Nelleke P M Brouwer, Rutger C H Stijns, Valery E P P Lemmens, et al.
The Lancet Regional Health. Europe|April 6, 2026
Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based studyDillen C van der Aa, Mats D Teeken, Hanneke W M van Laarhoven, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2024
Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the NetherlandsJulie F M Geerts, Marieke Pape, Pauline A J Vissers, et al.
Annals of Surgical Oncology|February 6, 2019
Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal CancerZ Faiz, M van Putten, R H A Verhoeven, et al.
Pageof 22